Abstract
During pre- and early postnatal development, the neurotransmitter serotonin (5-HT) modulates cell proliferation, migration and programmed cell death, as well as cell shape and cell-cell coupling. These “trophic” effects of 5-HT, involving the cytoskeletal function, the cell cycle, and programmed cell death, can be both dependent and independent of the changes in resting membrane potential that typically define neurotransmitter action. The morphogenetic role of 5-HT is neither limited to the central nervous system (CNS), nor does it impinge upon just a single aspect of cell biology. Ontogenic differences in regional and temporal expression patterns of 5-HT receptors mediating these effects in different systems add further complexity. This review summarizes neurobiological evidence for the trophic involvement of 5-HT during development and discusses related medical issues, including potential teratological risks and possible novel therapeutic indications of selective serotonin reuptake inhibitor (SSRI) administration.
Keywords: 5-hydroxytryptamine, 5-ht receptor, actin, barrel, monoamine oxidase a, serotonin transporter, vesicular monoamine transporter, whisker
Current Neuropharmacology
Title: Roles for Serotonin in Neurodevelopment: More than just Neural Transmission
Volume: 2 Issue: 4
Author(s): G. Di Pino, R. Moessner, K. P. Lesch, J. M. Lauder and A. M. Persico
Affiliation:
Keywords: 5-hydroxytryptamine, 5-ht receptor, actin, barrel, monoamine oxidase a, serotonin transporter, vesicular monoamine transporter, whisker
Abstract: During pre- and early postnatal development, the neurotransmitter serotonin (5-HT) modulates cell proliferation, migration and programmed cell death, as well as cell shape and cell-cell coupling. These “trophic” effects of 5-HT, involving the cytoskeletal function, the cell cycle, and programmed cell death, can be both dependent and independent of the changes in resting membrane potential that typically define neurotransmitter action. The morphogenetic role of 5-HT is neither limited to the central nervous system (CNS), nor does it impinge upon just a single aspect of cell biology. Ontogenic differences in regional and temporal expression patterns of 5-HT receptors mediating these effects in different systems add further complexity. This review summarizes neurobiological evidence for the trophic involvement of 5-HT during development and discusses related medical issues, including potential teratological risks and possible novel therapeutic indications of selective serotonin reuptake inhibitor (SSRI) administration.
Export Options
About this article
Cite this article as:
Pino Di G., Moessner R., Lesch P. K., Lauder M. J. and Persico M. A., Roles for Serotonin in Neurodevelopment: More than just Neural Transmission, Current Neuropharmacology 2004; 2 (4) . https://dx.doi.org/10.2174/1570159043359495
DOI https://dx.doi.org/10.2174/1570159043359495 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Hsp70 Molecular Chaperones: Emerging Roles in Human Disease and Identification of Small Molecule Modulators
Current Topics in Medicinal Chemistry Differential Binding Preference of Methylpheophorbide a and Its Diboronated Derivatives to Albumin and Low Density Lipoproteins
Anti-Cancer Agents in Medicinal Chemistry Good, Bad, Mobile Elements: Genome’s Most Successful “Parasites” as Emerging Players in Cell and Organismal Aging
Current Pharmaceutical Design HR+, HER2– Advanced Breast Cancer and CDK4/6 Inhibitors: Mode of Action, Clinical Activity, and Safety Profiles
Current Cancer Drug Targets A Family of Pleiotropically Acting MicroRNAs in Cancer Progression, miR-200: Potential Cancer Therapeutic Targets
Current Pharmaceutical Design Molecular Approaches Target to Immunotherapy for HPV-Associated Cancers
Current Cancer Drug Targets Metabolomics Applications in Precision Medicine: An Oncological Perspective
Current Topics in Medicinal Chemistry Mitochondrial Signaling and Hepatocellular Carcinoma: Molecular Mechanisms and Therapeutic Implications
Current Pharmaceutical Design Sphingolipid Metabolism and Leukemia: A Potential for Novel Therapeutic Approaches
Anti-Cancer Agents in Medicinal Chemistry Oncolytic Virotherapy and Gene Therapy Strategies for Hepatobiliary Cancers
Current Cancer Drug Targets The Current and Future Therapies for Human Osteosarcoma
Current Cancer Therapy Reviews Novel Methods of Genetic Modification of Human Pluripotent Stem Cells
Recent Patents on Regenerative Medicine Differential Expression of miR-20a and miR-145 in Colorectal Tumors as Potential Location-specific miRNAs
MicroRNA MRP1-dependent Collateral Sensitivity of Multidrug-resistant Cancer Cells: Identifying Selective Modulators Inducing Cellular Glutathione Depletion
Current Medicinal Chemistry Hsp90: A Novel Target for Cancer Therapy
Current Topics in Medicinal Chemistry Multidrug Transporters as Drug Targets
Current Drug Targets Reproductive Effects of Low-to-Moderate Medical Radiation Exposure
Current Medicinal Chemistry Identification and Preclinical Evaluation of SC144, a Novel Pyrroloquinoxaline Derivative with Broad-Spectrum Anticancer Activity
Mini-Reviews in Medicinal Chemistry Structure and Function of the Epstein-Barr Virus Transcription Factor, EBNA 3C
Current Protein & Peptide Science The Pathophysiological Role of PEDF in Bone Diseases
Current Molecular Medicine